Abstract: Provided is a gene expression reinforcement system for a recombinant bagworm fibroin H chain protein. The system includes a gene encoding a modified recombinant bagworm fibroin H chain protein in which either the N-terminal domain or the C-terminal domain constituting the recombinant bagworm fibroin H chain protein has been partially or entirely deleted.

Abstract: Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin.

Abstract: Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin.

Abstract: Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin.

Abstract: According to one embodiment, there is provided a second block that is connectable via an interface cable to a first block serving as a signal source, and supplies a high-resolution display with image data of a high resolution. The second block has an information transmitter for transmitting particular resolution information different from the high resolution when the resolution information of the high-resolution display is transmitted to the first block. The second block also has an image decoder for decoding, into image data of the high resolution, the image data processed based on the particular resolution information and sent from the first block. The decoded high-resolution image data is output to the high-resolution display.

Abstract: The present invention provides a low molecular weight compound having EPO production-promoting action and/or hemoglobin production-promoting action. The present invention relates to a fused piperidine compound represented by the following general formula (1): (wherein, ring A represents a C10-14 aryl group or 5- to 10-membered heterocyclic group, X represents N—R7, a sulfur atom or an oxygen atom, R1, R2, R2?, R3 and R3? independently represent a hydrogen atom, C1-6 alkyl group or C3-6 cycloalkyl group, and R4, R5 and R6 independently represent a hydrogen atom or halogen atom), or a salt thereof, or a solvate thereof.

Abstract: To provide a novel JAK3 inhibitor that is useful as a preventive and/or therapeutic agent for rejection and graft versus host disease (GvHD) in organ transplantation, rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, Sjögren syndrome, Behcet's disease, type I diabetes mellitus, autoimmune thyroiditis, idiopathic thrombocytopenic purpura, ulcerative colitis, Crohn's disease, asthma, allergic rhinitis, atopic dermatitis, contact dermatitis, urticaria, eczema, psoriasis, allergic conjunctivitis, uveitis, cancer, leukemia and the like. The pyridine-3-carboxyamide derivative represented by the general formula (1): or its salt or a solvate thereof.

Abstract: The present invention provides a low molecular weight compound having EPO production-promoting action and/or hemoglobin production-promoting action. The present invention relates to a fused piperidine compound represented by the following general formula (1): (wherein, ring A represents a C10-14 aryl group or 5- to 10-membered heterocyclic group, X represents N—R7, a sulfur atom or an oxygen atom, R1, R2, R2?, R3 and R3? independently represent a hydrogen atom, C1-6 alkyl group or C3-6 cycloalkyl group, and R4, R5 and R6 independently represent a hydrogen atom or halogen atom), or a salt thereof, or a solvate thereof.

Abstract: Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin.

Abstract: A display screen of an onboard display device is disposed so that a speedometer is displayed in front of a driver of a vehicle. When a right-turn instruction is detected, a blinker is displayed and a rightward rear view image outside the vehicle is displayed on the right side of the display screen. When a left-turn instruction is detected, a blinker is displayed and a leftward rear view image outside the vehicle is displayed on the left side of the display screen. Displaying the image in different positions of the display screen according to the right or the left turn instruction facilitates an intuitive determination of a meaning of the image and makes it easier to drive the vehicle.

Abstract: To provide a novel JAK3 inhibitor that is useful as a preventive and/or therapeutic agent for rejection and graft versus host disease (GvHD) in organ transplantation, rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, Sjögren syndrome, Behcet's disease, type I diabetes mellitus, autoimmune thyroiditis, idiopathic thrombocytopenic purpura, ulcerative colitis, Crohn's disease, asthma, allergic rhinitis, atopic dermatitis, contact dermatitis, urticaria, eczema, psoriasis, allergic conjunctivitis, uveitis, cancer, leukemia and the like. The pyridine-3-carboxyamide derivative represented by the general formula (1): or its salt or a solvate thereof.

Abstract: An onboard display device includes a display section attached to an instrument panel of a vehicle. The section has a second display area and a first display area. The second display area shows at least the speed as vehicle condition images indicating the conditions of the vehicle. The first display area shows a navigation image and other secondary images. The display section measures greater in width than in height with an aspect ratio of 7:3 or greater. The aspect ratio is the width/height ratio of a display area. The onboard display device allows for a visibility-improved simultaneous display of the secondary image, such as a navigation image, and the vehicle condition image, such as a speed display, which presents information on the conditions of the vehicle.

Abstract: In a condition detection and display system (100), an omnidirectional camera (1), internal condition sensors (3), external condition sensors (4), and others detect a condition of a vehicle and surroundings around the vehicle, image data which is a detection result obtained by the aforesaid members and contains an image of the vehicle is selected from an image database (6), and the selected image data is displayed on a liquid crystal panel (7) at a position close to a display of a speedometer.

Abstract: An onboard display device includes a display section attached to an instrument panel of a vehicle. The section has a second display area and a first display area. The second display area shows at least the speed as vehicle condition images indicating the conditions of the vehicle. The first display area shows a navigation image and other secondary images. The display section measures greater in width than in height with an aspect ratio of 7:3 or greater. The aspect ratio is the width/height ratio of a display area. The onboard display device allows for a visibility-improved simultaneous display of the secondary image, such as a navigation image, and the vehicle condition image, such as a speed display, which presents information on the conditions of the vehicle.

Abstract: Disclosed is a low-molecular-weight compound having an EPO production-promoting activity and/or a hemoglobin expression-enhancing activity. Specifically disclosed is an EPO production promoter and/or a hemoglobin expression enhancer comprising a 1-acyl-4-(phenoxy, benzyloxy or phenylamino)-1,2,3,4-tetrahydroquinoline derivative, more specifically a tetrahydroquinoline compound represented by the general formula (1); [wherein R1, R2, R2?, R3 and R3? independently represent a hydrogen atom, a C1-6 alkyl group, or the like; R4, R5, R6, R7, R8, R9 and R10 independently represent a hydrogen atom, a halogen atom, a C1-6 alkyl group, or the like; A represents N—R11 or an oxygen atom; R11 represents a hydrogen atom, a C1-6 alkyl group, or the like; and n represents an integer of 0 or 1], a salt of the tetrahydroquinoline compound, or a solvate of the tetrahydroquinoline compound or the salt.

Abstract: Facilitating viewer comparison of a plurality of medical images of at least one body part on a softcopy review workstation is described. First and second medical images are displayed such that the second medical image appears as a spatially registered underlay to the first medical image exposed through an aperture therein. The aperture comprises at least one edge that is viewer-manipulable in a back-and-forth manner so that the first and second medical images can be visually compared with minimal eye movement. For a temporal comparison embodiment, the first and second medical images comprise identical views of the same body part acquired at different times. For a cross-modality comparison embodiment, the first and second medical images are acquired substantially concurrently, or at different times, using different medical imaging modalities. For a bilateral comparison embodiment, the first and second images are corresponding views of two laterally corresponding body parts.

Abstract: A liquid crystal display device (100) includes mean value computing sections (9a, 9b) and an optical intensity regulation section (11). The mean value computing section (9a) outputs a mean luminance level (A1) for the pixels forming an image display produced in a driver seat display area (2). The mean value computing section (9b) outputs a mean luminance level (A2) for the pixels forming an image display produced in a front passenger seat display area (3). The optical intensity regulation section (11) controls (regulates) the output optical intensity of backlights (4a, 4b) according to the mean luminance level (A1) and the mean luminance level (A2). As a result, the luminance of the image display in the front passenger seat display area (3) is further limited than the luminance of the image display in the driver seat display area (2). The control ensures high visibility of image displays for the driver.

Abstract: A method, system, and related computer program products are provided for processing a medical image of a body part according to a computer-aided detection (CAD) algorithm, the medical image having an image border, the body part comprising imaged tissue appearing inside the image border and outlying tissue not appearing in the medical image, wherein likely anatomical abnormalities in the outlying tissue near the imaged tissue border are detected by the CAD algorithm. In one example, the detected likely abnormalities in the outlying tissue are located within a first distance from the imaged tissue border, wherein the first distance corresponds to a spatial ambit of a neighborhood-based feature computed by the CAD algorithm.

Abstract: There is provided a system for showing a multi-directional image of surroundings of transportation device requiring a manual maneuver, when starting the transportation device in a parked state (stop state). The surroundings exhibiting system is constituted by an omnidirectional camera, an ignition instruction detection sensor, a control section including a CPU and a frame memory, and a liquid crystal panel. The omnidirectional camera captures an omnidirectional image of the surroundings around the transportation device in synchronization with a driver's ignition instruction detected by the ignition instruction detection sensor. Further, the captured image data is temporally stored in the frame memory, and the stored image data is sequentially transmitted to the liquid crystal panel so as to be displayed thereon.

Abstract: The present invention is directed to a ?-globin inducer, to a prophylactic and/or therapeutic agent for sickle cell disease, and to a prophylactic and/or therapeutic agent for ?-thalassemia, each containing, as an active ingredient, 4-[N-(4-methoxyphenyl)-N-[[5-(3,4,5-trimethoxyphenyl)pyridin-3-yl]methyl]amino]-1-[[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl]piperidine, a salt thereof, or a solvate of either of these.